促销时间表 Exelixis
先进的时间表
简单图表
关于公司 Exelixis
Exelixis, Inc. - биотехнологическая компания, специализирующаяся на разработке перспективных низкомолекулярных препаратов для лечения рака и других серьёзных заболеваний, в том числе поражения почек, рака щитовидной железы и прогрессирующей меланомы. Кроме того, компания создаёт стратегические партнёрства с другими фармацевтическими и биотехнологическими компаниями.IPO date | 2000-04-07 |
---|---|
ISIN | US30161Q1040 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.exelixis.com |
Цена ао | 36.02 |
每日价格变化: | -5.13% (34.13) |
---|---|
每周价格变化: | -10.55% (36.2) |
每月价格变化: | -4.26% (33.82) |
3个月内价格变化: | +16.18% (27.87) |
六个月内的价格变化: | +39.15% (23.27) |
每年价格变化: | +46.38% (22.12) |
3年内价格变化: | +56.2% (20.73) |
5年内价格变化: | +72.88% (18.73) |
10年价格变化: | +646.08% (4.34) |
年初以来价格变化: | -2.73% (33.29) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
交易日期 | 披露日期 | 内幕 | 类型 | 价格 | 体积 | 数量 | 分享最多, % | 之后分享, % | 文档 |
---|---|---|---|---|---|---|---|---|---|
18.11.2024 | 18.11.2024 | Haley Patrick J. Officer |
购买 | 34.41 | 666 900 | 19381 | 0 | 0.01 | 关联 |
02.10.2024 | 03.10.2024 | Haley Patrick J. EVP, Commercial |
购买 | 24.41 | 2 441 000 | 100000 | 0 | 0.03 | 关联 |
01.10.2024 | 03.10.2024 | MORRISSEY MICHAEL President and CEO |
购买 | 24.41 | 11 716 800 | 480000 | 0 | 0.15 | 关联 |
23.09.2024 | 25.09.2024 | Hessekiel Jeffrey EVP & General Counsel |
销售 | 26.38 | 659 500 | 25000 | 0 | -0.01 | 关联 |
26.08.2024 | 28.08.2024 | Hessekiel Jeffrey EVP, General Counsel & Sec |
销售 | 25.79 | 515 800 | 20000 | 0 | -0.01 | 关联 |
26.08.2024 | 28.08.2024 | Hessekiel Jeffrey EVP, General Counsel & Sec |
购买 | 24.41 | 488 200 | 20000 | 0 | 0.01 | 关联 |
14.08.2024 | 16.08.2024 | Freire Maria C Director |
销售 | 26.56 | 219 120 | 8250 | 0 | 0 | 关联 |
12.08.2024 | 14.08.2024 | Aftab Dana CSO/EVP Disc & Trans Research |
销售 | 27.06 | 565 094 | 20883 | 0 | -0.01 | 关联 |
09.08.2024 | 09.08.2024 | Senner Christopher J. EVP and CFO |
销售 | 27.19 | 3 398 750 | 125000 | 0 | -0.04 | 关联 |
09.08.2024 | 09.08.2024 | Senner Christopher J. EVP and CFO |
购买 | 24.41 | 3 051 250 | 125000 | 0 | 0.04 | 关联 |
08.08.2024 | 12.08.2024 | POSTE GEORGE Director |
销售 | 26.89 | 906 865 | 33725 | 0 | -0.01 | 关联 |
07.08.2024 | 09.08.2024 | Hessekiel Jeffrey EVP, General Counsel & Sec |
销售 | 25.97 | 2 077 600 | 80000 | 0 | -0.03 | 关联 |
07.08.2024 | 09.08.2024 | Hessekiel Jeffrey EVP, General Counsel & Sec |
购买 | 24.41 | 1 952 800 | 80000 | 0 | 0.03 | 关联 |
07.08.2024 | 09.08.2024 | Haley Patrick J. EVP, Commercial |
销售 | 25.5 | 357 000 | 14000 | 0 | 0 | 关联 |
07.08.2024 | 09.08.2024 | Aftab Dana CSO/EVP Disc & Trans Research |
销售 | 25 | 2 375 000 | 95000 | 0 | -0.03 | 关联 |
07.08.2024 | 09.08.2024 | Aftab Dana CSO/EVP Disc & Trans Research |
购买 | 24.41 | 2 318 950 | 95000 | 0 | 0.03 | 关联 |
04.06.2024 | 06.06.2024 | WYSZOMIERSKI JACK L Director |
销售 | 22 | 182 314 | 8287 | 0 | 0 | 关联 |
30.05.2024 | 30.05.2024 | JOHNSON DAVID EDWARD Director |
购买 | 20.76 | 4 671 000 | 225000 | 0 | 0.07 | 关联 |
28.05.2024 | 30.05.2024 | JOHNSON DAVID EDWARD Director |
购买 | 20.32 | 4 064 000 | 200000 | 0 | 0.06 | 关联 |
20.05.2024 | 22.05.2024 | PAPADOPOULOS STELIOS Director |
销售 | 21 | 240 177 | 11437 | 0 | 0 | 关联 |
20.05.2024 | 22.05.2024 | PAPADOPOULOS STELIOS Director |
购买 | 19.57 | 228 695 | 11686 | 0 | 0 | 关联 |
13.05.2024 | 15.05.2024 | WYSZOMIERSKI JACK L Director |
销售 | 21.37 | 233 425 | 10923 | 0 | 0 | 关联 |
13.05.2024 | 15.05.2024 | WYSZOMIERSKI JACK L Director |
购买 | 19.57 | 228 695 | 11686 | 0 | 0 | 关联 |
21.03.2024 | 25.03.2024 | Garber Alan M Director |
销售 | 24.01 | 461 112 | 19205 | 0 | -0.01 | 关联 |
21.03.2024 | 25.03.2024 | Garber Alan M Director |
购买 | 19.57 | 459 719 | 23491 | 0 | 0.01 | 关联 |
04.12.2023 | 04.12.2023 | Hessekiel Jeffrey EVP, General Counsel & Sec |
销售 | 22.06 | 551 500 | 25000 | 0 | -0.01 | 关联 |
30.11.2023 | 04.12.2023 | Hessekiel Jeffrey EVP, General Counsel & Sec |
销售 | 22.01 | 550 250 | 25000 | 0 | -0.01 | 关联 |
30.08.2023 | 01.09.2023 | Aftab Dana CSO/EVP Disc & Trans Research |
销售 | 22.47 | 103 362 | 4600 | 0 | 0 | 关联 |
28.08.2023 | 30.08.2023 | MORRISSEY MICHAEL President and CEO |
购买 | 15.31 | 5 511 600 | 360000 | 0 | 0.11 | 关联 |
03.08.2023 | 07.08.2023 | Haley Patrick J. EVP, Commercial |
销售 | 20.67 | 631 531 | 30553 | 0 | -0.01 | 关联 |
01.03.2023 | 03.03.2023 | Hessekiel Jeffrey EVP, General Counsel & Sec |
销售 | 17.13 | 1 333 740 | 77860 | 0 | -0.02 | 关联 |
01.03.2023 | 03.03.2023 | Hessekiel Jeffrey EVP, General Counsel & Sec |
购买 | 14.74 | 410 656 | 27860 | 0 | 0.01 | 关联 |
15.12.2022 | 16.12.2022 | Lamb Peter EVP, Scientific Strategy & CSO |
销售 | 15.88 | 317 600 | 20000 | 0 | -0.01 | 关联 |
15.12.2022 | 16.12.2022 | Lamb Peter EVP, Scientific Strategy & CSO |
购买 | 4.2 | 84 000 | 20000 | 0 | 0.01 | 关联 |
12.09.2022 | 14.09.2022 | Haley Patrick J. EVP, Commercial |
销售 | 17.94 | 717 600 | 40000 | 0 | -0.01 | 关联 |
12.09.2022 | 14.09.2022 | Haley Patrick J. EVP, Commercial |
购买 | 6.21 | 248 400 | 40000 | 0 | 0.01 | 关联 |
11.08.2022 | 12.08.2022 | Senner Christopher J. EVP and CFO |
购买 | 6.21 | 1 397 250 | 225000 | 0 | 0.07 | 关联 |
01.04.2022 | 04.04.2022 | Haley Patrick J. EVP, Commercial |
销售 | 23 | 230 000 | 10000 | 0 | 0 | 关联 |
01.04.2022 | 04.04.2022 | Haley Patrick J. EVP, Commercial |
购买 | 6.21 | 62 100 | 10000 | 0 | 0 | 关联 |
31.03.2022 | 04.04.2022 | Haley Patrick J. EVP, Commercial |
销售 | 22.43 | 224 300 | 10000 | 0 | 0 | 关联 |
31.03.2022 | 04.04.2022 | Haley Patrick J. EVP, Commercial |
购买 | 6.21 | 62 100 | 10000 | 0 | 0 | 关联 |
29.03.2022 | 30.03.2022 | Hessekiel Jeffrey EVP, General Counsel & Sec |
销售 | 22 | 292 226 | 13283 | 0 | 0 | 关联 |
28.03.2022 | 30.03.2022 | Hessekiel Jeffrey EVP, General Counsel & Sec |
销售 | 22 | 103 774 | 4717 | 0 | 0 | 关联 |
03.02.2022 | 04.02.2022 | Haley Patrick J. EVP, Commercial |
销售 | 17.91 | 1 074 600 | 60000 | 0 | -0.02 | 关联 |
03.02.2022 | 04.02.2022 | Haley Patrick J. EVP, Commercial |
购买 | 1.9 | 114 000 | 60000 | 0 | 0.02 | 关联 |
15.12.2021 | 17.12.2021 | Lamb Peter EVP, Scientific Strategy & CSO |
销售 | 17.44 | 828 400 | 47500 | 0 | -0.02 | 关联 |
15.12.2021 | 17.12.2021 | Lamb Peter EVP, Scientific Strategy & CSO |
购买 | 6.21 | 294 975 | 47500 | 0 | 0.02 | 关联 |
24.11.2021 | 26.11.2021 | Haley Patrick J. EVP, Commercial |
销售 | 17.25 | 297 321 | 17236 | 0 | -0.01 | 关联 |
21.09.2021 | 23.09.2021 | Senner Christopher J. EVP and CFO |
购买 | 3.66 | 329 400 | 90000 | 0 | 0.03 | 关联 |
26.07.2021 | 28.07.2021 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
购买 | 4.2 | 168 000 | 40000 | 0 | 0.01 | 关联 |
21.07.2021 | 23.07.2021 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
购买 | 4.2 | 147 000 | 35000 | 0 | 0.01 | 关联 |
15.07.2021 | 16.07.2021 | Lamb Peter EVP, Scientific Strategy & CSO |
销售 | 17.47 | 1 048 200 | 60000 | 0 | -0.02 | 关联 |
15.07.2021 | 16.07.2021 | Lamb Peter EVP, Scientific Strategy & CSO |
购买 | 1.9 | 114 000 | 60000 | 0 | 0.02 | 关联 |
17.06.2021 | 22.06.2021 | Lamb Peter EVP, Scientific Strategy & CSO |
销售 | 22.18 | 1 330 800 | 60000 | 0 | -0.02 | 关联 |
26.04.2021 | 28.04.2021 | Hessekiel Jeffrey EVP and General Counsel |
销售 | 25.03 | 450 540 | 18000 | 0 | -0.01 | 关联 |
26.04.2021 | 28.04.2021 | Haley Patrick J. EVP, Commercial |
销售 | 25.03 | 191 855 | 7665 | 0 | 0 | 关联 |
26.04.2021 | 28.04.2021 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
销售 | 25 | 1 250 000 | 50000 | 0 | -0.02 | 关联 |
26.04.2021 | 28.04.2021 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
购买 | 1.7 | 85 000 | 50000 | 0 | 0.02 | 关联 |
24.02.2021 | 26.02.2021 | COHEN CHARLES Director |
销售 | 22.69 | 907 600 | 40000 | 0 | -0.01 | 关联 |
24.02.2021 | 26.02.2021 | COHEN CHARLES Director |
购买 | 3.38 | 135 200 | 40000 | 0 | 0.01 | 关联 |
10.11.2020 | 13.11.2020 | WYSZOMIERSKI JACK L Director |
销售 | 20.61 | 700 740 | 34000 | 0 | -0.01 | 关联 |
10.11.2020 | 13.11.2020 | WYSZOMIERSKI JACK L Director |
购买 | 5.82 | 363 185 | 62403 | 0 | 0.02 | 关联 |
机构 | 体积 | 分享, % |
---|---|---|
Blackrock Inc. | 36014432 | 11.88 |
Vanguard Group Inc | 31671090 | 10.45 |
Farallon Capital Management Llc | 26634500 | 8.78 |
Renaissance Technologies, LLC | 15615716 | 5.15 |
State Street Corporation | 13032818 | 4.3 |
JP Morgan Chase & Company | 7741589 | 2.55 |
Geode Capital Management, LLC | 5145318 | 1.7 |
Morgan Stanley | 4774731 | 1.57 |
Dimensional Fund Advisors LP | 4560517 | 1.5 |
Stephens Investment Management Group | 4106664 | 1.35 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Dr. Stelios Papadopoulos Ph.D. | Co-Founder & Chair of the Board | 109k | 1948 (77 年) |
Mr. Christopher J. Senner | Executive VP & CFO | 1.09M | 1968 (57 年) |
Ms. Susan T. Hubbard | Executive Vice President of Public Affairs & Investor Relations | N/A | |
Dr. Michael M. Morrissey Ph.D. | CEO, President & Director | 2.31M | 1961 (64 年) |
Mr. Jeffrey J. Hessekiel J.D. | Executive VP, General Counsel & Secretary | 959.68k | 1969 (56 年) |
Dr. Dana T. Aftab Ph.D. | Executive VP of Discovery and Translational Research & Chief Scientific Officer | N/A | 1964 (61 年) |
Mr. Patrick J. Haley M.B.A. | Executive Vice President of Commercial | 844.64k | 1976 (49 年) |
Dr. Anne Champsaur M.D. | Senior Vice President of Drug Safety | N/A | |
Dr. Amy C. Peterson M.D. | Executive VP, Product Development & Medical Affairs and Chief Medical Officer | 1967 (58 年) | |
Dr. William Berg M.D. | Senior Vice President of Medical Affairs |
地址: United States, Alameda, CA , 1851 Harbor Bay Parkway - 在 Google 地图中打开, 打开 Yandex 地图
网站: http://www.exelixis.com
网站: http://www.exelixis.com